JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 24, 2006; DOI: 10.1124/jpet.106.103135


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.103135v1
318/1/268    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alkondon, M.
Right arrow Articles by Albuquerque, E. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alkondon, M.
Right arrow Articles by Albuquerque, E. X.


Received for publication February 22, 2006.
Revised March 21, 2006.
Accepted for publication March 23, 2006.

Subtype-specific inhibition of nicotinic acetylcholine receptors by choline: a regulatory pathway

Manickavasagom Alkondon 1 Edson X. Albuquerque 1*

1 University of Maryland School of Medicine

* Address correspondence to: E-mail: ealbuque{at}umaryland.edu

Abstract

Choline is an essential nutrient and a precursor of neurotransmitter ACh and is produced at synapses during depolarization, upon hydrolysis of ACh via acetylcholinesterase, and under conditions of injury and trauma. Animal studies have shown that supplementation with choline during early development results in long-lasting improvement in memory in adults; however, the mechanisms underlying this effect are poorly defined. Previous studies revealed that choline interacts with type IA ({alpha}7*) nicotinic acetylcholine receptors (nAChRs) as a full agonist and as a desensitizing agent, and is a weak agonist of type III ({alpha}3{beta}4*) nAChRs. Since nAChRs play a role in learning and memory and are generally inhibited by agonists at low concentrations, we investigated in this study the inhibitory effects of choline on non-{alpha}7 nAChRs such as type II ({alpha}4{beta}2*) and type III nAChRs. Using whole-cell patch-clamp recordings from neurons of rat hippocampal and dorsal striatal slices, we demonstrate that choline inhibits type III nAChR-mediated glutamate EPSCs. Choline inhibited ACh-induced NMDA EPSCs in CA1 stratum radiatum (SR) interneurons of rat hippocampal slices with an IC50 of {approx}15 µM. Choline did not inhibit NMDA or AMPA receptors in CA1 SR interneurons. Choline inhibited type II nAChRs in CA1 SR interneurons with an IC50 of {approx}370 µM. The present results reveal an order of inhibitory potency for choline type III >type IA > type II nAChRs. It is concluded that brain nAChRs, but not glutamate receptors, are the primary targets for the regulatory actions of choline.


Key words: AMPA EPSC, Betaine, NMDA EPSC, choline, nicotinic receptors, rat hippocampal slices


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
N. Innocent, P. D. Livingstone, A. Hone, A. Kimura, T. Young, P. Whiteaker, J. M. McIntosh, and S. Wonnacott
{alpha}Conotoxin Arenatus IB[V11l,V16D] Is a Potent and Selective Antagonist at Rat and Human Native {alpha}7 Nicotinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 529 - 537.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Alkondon, E. F. R. Pereira, M. C. Potter, F. C. Kauffman, R. Schwarcz, and E. X. Albuquerque
Strain-Specific Nicotinic Modulation of Glutamatergic Transmission in the CA1 Field of the Rat Hippocampus: August Copenhagen Irish Versus Sprague-Dawley
J Neurophysiol, February 1, 2007; 97(2): 1163 - 1170.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.